PEG-MGF 2mg

Waiting on testing to release ETA 08/31 PEGylated Mechano Growth Factor | Research Use Only PEG-MGF is a synthetic, PEGylated form of the peptide commonly referred to as Mechano Growth Factor (MGF). MGF is associated with an alternatively spliced isoform of the insulin-like growth factor-1 (IGF-1) gene and has been investigated extensively in laboratory models involving cellular signaling, tissue-response pathways, and regenerative biology. The PEG portion refers to polyethylene glycol. PEGylation is a laboratory modification in which polyethylene glycol is conjugated to a peptide or other biological molecule, altering properties such as molecular size, solubility, stability, and degradation characteristics. Research Background MGF and related MGF E-domain peptides have been evaluated in a variety of in-vitro and preclinical research models. Published experimental research has examined MGF-related peptides in areas including: Cellular proliferation and differentiation pathways Skeletal-muscle cell and satellite-cell models Tissue-response and regeneration signaling Osteoblast and bone-healing research models Tendon-injury models Cardiovascular tissue-response models Cellular survival and apoptosis signaling For example, laboratory studies have reported effects of MGF-derived peptides on satellite-cell proliferation and differentiation. Preclinical research has also investigated MGF-derived peptides in rat tendon and bone-defect models, where researchers evaluated cellular and tissue-healing responses. Additional animal-model research has examined MGF E-domain peptides in cardiovascular tissue following experimental injury. These findings represent experimental observations from laboratory and preclinical research and should not be interpreted as demonstrating safety or effectiveness in humans. Why PEGylated MGF Is Studied PEGylation is frequently investigated as a method of modifying peptide characteristics. Attachment of polyethylene glycol can alter a peptide’s physical and chemical behavior and may increase resistance to degradation or extend stability under certain experimental conditions. PEG-MGF therefore provides researchers with a modified MGF-related peptide for comparative studies involving: PEGylated versus non-PEGylated peptides Peptide stability Molecular degradation Cell-signaling pathways Tissue-response models Analytical characterization Product Specifications Product: PEG-MGF Quantity: 2 mg Form: Lyophilized peptide Category: Research Peptide Research Classification: PEGylated MGF-related peptide Testing: Batch-specific analytical testing available through the corresponding Certificate of Analysis (COA) Intended Use: Laboratory and analytical research only Certificate of Analysis Refer to the current batch-specific Certificate of Analysis (COA) for analytical information associated with this product, including available identity, purity, content, and other testing data. Batch-specific COA results should be considered the authoritative analytical specifications for the individual lot supplied. Research Use Only FOR RESEARCH USE ONLY. NOT FOR HUMAN OR VETERINARY USE. PEG-MGF 2 mg is supplied exclusively as a laboratory research material. It is not intended for human consumption, veterinary use, diagnostic use, therapeutic use, or any form of administration to humans or animals. This product is not a drug, dietary supplement, food, cosmetic, or medical product. No information provided on this page is intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition. References to published scientific research are provided solely to describe areas in which the compound or related peptides have been investigated under controlled experimental conditions. Research = Results.